Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy

Detalles Bibliográficos
Autores principales: Burn, John, Mathers, John C, Gerdes, Anne-Marie, Bisgaard, MarieLuise, Evans, Gareth, Eccles, Diana, Lindblom, Annika, Macrae, Findlay, Maher, Eamonn R, Mecklin, Jukka-Pekka, Moslein, Gabriela, Olschwang, Sylviane, Ramesar, Raj, Vasen, Hans FA, Wijnen, Juul, Barker, Gail, Elliott, Faye, Lynch, Henry, Bishop, D Tim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876277/
http://dx.doi.org/10.1186/1897-4287-8-S1-O5

Ejemplares similares

Ejemplares similares